Author:
Lu Chang,Zhao Yue,Jia Wei-Qi,Zhang Hui,Qi Huan,Xiang Wen-Sheng,Wang Ji-Dong,Wang Xiang-Jing
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology
Reference14 articles.
1. Zhang, Z. et al. Anthracyclines potentiate anti-tumor immunity: a new opportunity for chemoimmunotherapy. Cancer Lett. 369, 331–335 (2015).
2. Galm, U. et al. Antitumor antibiotics: bleomycin, enediynes, and mitomycin. Chem. Rev. 105, 739–758 (2005).
3. Duchnowska, R. et al. The role of anthracyclines and dose dense therapy in an adjuvant setting in HER-2 positive early breast cancer, in clinical practice. Oncol. Clin. Pract. 12, 8–11 (2016).
4. Rabbani, A., Finn, R. M. & Ausio, J. The anthracycline antibiotics: antitumor drugs that alter chromatin structure. Bioessays 27, 50–56 (2005).
5. Demain, A. L. & Sanchez, S. Microbial drug discovery: 80 years of progress. J. Antibiot. 62, 5–16 (2009).
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献